Both in Pharmaceuticals
Ionis Pharmaceuticals vs Spyre Therapeutics
Over the past year IONS returned −28.5% and SYRE returned +417.8%; their daily moves had a correlation of 0.21.
IONS −28.5% SYRE +417.8%Growth of $1, one year, split-adjusted
| Metric | IONS | SYRE |
|---|---|---|
| Price | $45.89 | $84.72 |
| Market cap | $7.63B | $7.47B |
| Today | +0.70% | −1.25% |
| 1 month | −24.8% | −6.2% |
| 6 months | −36.7% | +86.5% |
| Year to date | −42.0% | +158.6% |
| 1 year | −28.4% | +421.7% |
| Revenue growth (YoY) | −40.7% | — |
| Gross margin | 99.0% | — |
| Net margin | −42.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.7× | — |
| Net cash | $732.0M | $1.15B |
| Dividend yield | — | — |
| Volatility (60d) | 71.8% | 55.1% |
| Short % of float | 12.8% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).